OSI-027

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OSI-027, covering 2013-04-15 to 2013-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]